<ѻýҕl>Off-Label Drug Lowers Relapses in Multiple Sclerosisѻýҕl> Study paves way for rituximab to be considered for MS in some countries Jul 21, 2022
<ѻýҕl>Alzheimer's-Gut Links; Long COVID and ME/CFS; ALS Patient Gets Novel Brain Interfaceѻýҕl> News and commentary from the world of neurology and neuroscience Jul 19, 2022
<ѻýҕl>Sacral Neuromodulation Promising in Neurogenic Lower Urinary Dysfunctionѻýҕl> Refractory disease corrected, at least for the short term, in selected neurologic patients Jul 15, 2022
<ѻýҕl>Therapeutic Use of Cannabis: Risks, Benefits, Legalityѻýҕl> Increased availability and use challenge clinician knowledge to keep pace Jun 29, 2022
<ѻýҕl>Patient-Reported Outcomes Similar With Extended Natalizumab Dosing Intervalѻýҕl> NOVA trial looks at 6-week dosing to reduce PML risk Jun 09, 2022
<ѻýҕl>High Density of MS Patients in Wisconsin -- But Why?ѻýҕl> Health records show prevalence may be three times the norm in some areas Jun 07, 2022
<ѻýҕl>Plasma NfL Linked With Cognitive Processing Speed in Relapsing MSѻýҕl> Post hoc analysis of trial data shows inverse relationship Jun 05, 2022
<ѻýҕl>Quit MS Drugs or Keep Going?ѻýҕl> DISCOMS trial looks at whether MS patients should stop treatment as they age Jun 05, 2022
<ѻýҕl>Women With MS Use Social Media to Discuss Family Planningѻýҕl> Posts offer insight into risks, experiences during pregnancy Jun 04, 2022
<ѻýҕl>Silent Progression in Relapsing MS Tied to Brain Volume Lossѻýҕl> Findings highlight the need to better stratify MS patients in clinical practice May 16, 2022
<ѻýҕl>White MS Prevalence Predominance Debunkedѻýҕl> Burden of multiple sclerosis in Black Americans under-recognized for decades, researchers say Apr 29, 2022
<ѻýҕl>Keto Diet Bettered Fatigue, Depression in MSѻýҕl> Quality of life, disability showed improvements in phase II study Apr 28, 2022
<ѻýҕl>More Severe Multiple Sclerosis Seen Further Northѻýҕl> MS patients in higher latitudes experience faster decline Apr 18, 2022
<ѻýҕl>Sleep and Light Exposure; Patients Protest CMS Plan; Lamotrigine's Cardiac Risks?ѻýҕl> News and commentary from the world of neurology and neuroscience Mar 15, 2022
<ѻýҕl>MS Patients on Cladribine Show Fewer Relapsesѻýҕl> Real-world data analysis compares oral disease-modifying therapies Mar 01, 2022
<ѻýҕl>Stem Cell Transplantation Shows Benefits in Aggressive MSѻýҕl> No new relapses recorded after autologous transplant Feb 28, 2022
<ѻýҕl>Deep Learning Identifies PPMS Patients Who May Respond to Treatmentѻýҕl> Predictive enrichment could increase the power of future trials Feb 27, 2022
<ѻýҕl>Paramagnetic Rim Lesions Highly Specific in MS Diagnosisѻýҕl> Sensitivity, accuracy also high in prospective study Feb 26, 2022
<ѻýҕl>COVID Vax Response Still Impaired in Some MS Patients After Third Shotѻýҕl> Subset of multiple sclerosis patients seroconverted after third dose, however Feb 25, 2022
<ѻýҕl>Cialis and Brain Blood Flow; Sleep and Media Use; Can Tarantulas Solve Chronic Pain?ѻýҕl> News and commentary from the world of neurology and neuroscience Feb 15, 2022
<ѻýҕl>MS Risk Skyrockets After Epstein-Barr Virus, but Not Other Infectionsѻýҕl> Findings show "compelling evidence of causality" Jan 13, 2022
<ѻýҕl>Worse COVID-19 Outcomes for Disabled MS Patientsѻýҕl> But monoclonal antibodies offer hope for high-risk people, registry data show Nov 02, 2021
<ѻýҕl>MS Treatment: Early Aggressive or Escalation Therapy?ѻýҕl> Clinical trial, observational data may not be enough to decide best strategy Nov 01, 2021
<ѻýҕl>New MS Drug Does Not Appear to Increase COVID Severityѻýҕl> Most COVID cases were mild or moderate in patients treated with ofatumumab Oct 29, 2021
<ѻýҕl>Cannabis Use Common Among People With MSѻýҕl> Most don't ask for medical guidance, survey shows Oct 28, 2021
<ѻýҕl>How Should Patients With Autoimmune Diseases Approach COVID Vaccination?ѻýҕl> Mixed messaging and a lack of tailored research leaves providers and patients in the dark Oct 22, 2021
<ѻýҕl>Frequent MRI May Spot Active Secondary Progressive MS More Quicklyѻýҕl> "If you rely on having a clinical relapse, you may wait a long time" Oct 19, 2021
<ѻýҕl>HCQ and MS; Guillain-Barre and COVID Vax; Neural Fingerprints Can Tell Who You Areѻýҕl> News and commentary from the world of neurology and neuroscience Oct 19, 2021
<ѻýҕl>COVID Vaccine Response Varies With MS Treatment Typeѻýҕl> How this relates to infection outcomes or risk of infecting others is unknown Oct 18, 2021
<ѻýҕl>Quitting Smoking Tied to Slower Motor Decline in Multiple Sclerosisѻýҕl> Analysis suggests smoking cessation has benefits in MS Oct 17, 2021
<ѻýҕl>Slowly Expanding Lesions in MS Reduced With BTK Inhibitorѻýҕl> Evobrutinib shows effect on marker of chronic inflammation Oct 17, 2021
<ѻýҕl>Virtual Care May Help Multiple Sclerosis Patients Even After the Pandemicѻýҕl> Early study paves the way to look at how telehealth may fit into MS care Oct 15, 2021
<ѻýҕl>Novel Anti-CD20 Drug Shows Promise in Relapsing MSѻýҕl> Ublituximab bests teriflunomide in head-to-head phase III trials Oct 14, 2021
<ѻýҕl>Guillain-Barré and COVID; Head-to-Head Alzheimer's Blood Tests; Fastball EEGѻýҕl> News and commentary from the world of neurology and neuroscience Sep 28, 2021
<ѻýҕl>BTK Inhibitor Reduces New Lesions in Relapsing Multiple Sclerosisѻýҕl> Tolebrutinib may hold promise for progressive MS, too Sep 03, 2021
<ѻýҕl>Breast Cancer and MS: New Data Shed Light on Survivalѻýҕl> Study compares breast cancer patients with and without MS May 19, 2021
<ѻýҕl>BTK Inhibitor Cuts Marker of Neuronal Damage in Relapsing MSѻýҕl> Novel agent lowered neurofilament light chain levels, may help reduce neuroaxonal damage Apr 22, 2021
<ѻýҕl>Black MS Patients See More Rapid B-Cell Repopulationѻýҕl> May have implications for timing of lab draws and anti-CD20 dosing, researchers say Apr 20, 2021
<ѻýҕl>COVID Antibody Responses Reduced in Some MS Patientsѻýҕl> But T-cell responses were similar, even in patients on ocrelizumab Apr 19, 2021
<ѻýҕl>Novel Device OK'd to Treat MS Gait Deficitsѻýҕl> Tongue stimulator generates pulses to combat ataxia Mar 26, 2021